Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era

Affiliations

• ¹ Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
• ² Division of Hematology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
• ³ Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York, USA.
• ⁴ Hematology/Oncology, Duke University, Durham, North Carolina, USA.
• ⁵ Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati, Cincinnati, Ohio, USA.
• ⁶ Department of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA.
• ⁷ University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, USA.
• ⁸ City of Hope National Medical Center, Duarte, California, USA.
• ⁹ Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.
• ¹⁰ Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
• ¹¹ Division of Medical Oncology, University of Washington, Seattle, Washington, USA.
• ¹² Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ¹³ Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, New Jersey, USA.
• ¹⁴ Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
• ¹⁵ Novant Health Cancer Institute, Lymphoma and CLL Program, Charlotte, North Carolina, USA.
• ¹⁶ Division of Hematology, University of North Carolina, Chapel Hill, North Carolina, USA.
• ¹⁷ College of Medicine, The Ohio State University, Columbus, Ohio, USA.
• ¹⁸ Icahn School of Medicine at Mount Sinai, New York, New York, USA.